Insider trade

Cencora (COR)Chair sold ~$4.28M

Steven H Collis, Chair at Cencora, sold ~$4.28M of Cencora shares.

~$4.28M
Approx. value · 15K sh @ $293.84: 314K
Holds after · shares reported

Traded: May 20, 2025
Filed: May 21, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

Mar 24, 2025FDARecall: Voriconazole Tablets, 50 mg, packaged in cartons of 3 blister cards with 10 individual blistered doses (30 Unit Dose per carton), Rx only, Distributed by: Amer…
Mar 24, 2025Insider · 1 personInsiders: 2 sales (~$1.1M)
Mar 25, 2025Insider · 1 personInsiders: 2 sales (~$3.9M)
Mar 27, 2025CongressDisclosed sale of COR — reported range $15,001 - $50,000
Apr 2, 2025FDARecall: Haloperidol Decanoate Injection, 100 mg/mL*, 1 x 1 mL Single-Dose Vial, Rx only, Manufactured by: Somerset Therapeutics Limited, #54/1, Boodhihal Village, Nela…
Apr 2, 2025FDARecall: Haloperidol Decanoate Injection, 100mg/mL*, 5 x 1 mL Single-Dose Vials, Rx Only, Manufactured by: Somerset Therapeutics Limited, #54/1 Boodhihal Village, Nelam…
Apr 2, 2025FDARecall: Haloperidol Decanoate Injection, 50mg/mL* , 1 mL Single-Dose Vial, Rx only, Manufactured by Somerset Therapeutics Limited, 54/1, Boodhihal Village, Nelamangala…
Apr 21, 2025InsiderCEO sold ~$1.44M of COR shares in the open market
Apr 22, 2025InsiderChair sold ~$4.11M of COR shares in the open market
May 12, 2025CongressDisclosed sale of COR — reported range $50,001 - $100,000
May 14, 2025InsiderDirector sold ~$837K of COR shares in the open market
May 15, 2025FDARecall: Indomethacin Extended-Release Capsules, USP, 75 mg, 30 capsules (3 x 10 blister cards) per carton, Rx Only, Distributed by: American Health Packaging, Columbus…
May 19, 2025InsiderCEO sold ~$1.45M of COR shares in the open market
May 20, 2025 · this disclosureInsiderChair sold ~$4.28M of COR shares in the open market

What came next

View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Cencora

For Cencora, OQRO holds 7 insider filings (SEC Form 4 or Form 144), 1 Congress trade report, 29 fund holdings reports (13F) and 2 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its COR page.

Other recent filings by Steven H Collis, Executive Chairman

The full history of Steven H Collis, Executive Chairman is on the profile page.

How this filing works

Other disclosures at Cencora

Everything OQRO holds on this company is on its COR page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO Pro Already have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data